Vivesto
0.311 SEK -2.82%1 investor is following this company
Vivesto is a research company. The company specializes in the research and development of drugs for serious diseases in oncology. The technology is based on the company's technical platform where research is based on nanotechnology. Today, operations are conducted mainly in the Nordic countries and North America. The company was founded in 1999 and has its headquarters in Uppsala.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
VIVE
Daily low / high price
0.307 / 0.32
SEK
Market cap
167.06M SEK
Turnover
83.74K SEK
Volume
269K
Latest videos
Financial calendar
General meeting
2024-05-23
Interim report
2024-05-23
Interim report
2024-08-22
Interim report
2024-11-21
Annual report
2025-02-20
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Per Arwidsson med bolag | 24.8 % | 24.8 % |
Avanza Pension | 5.6 % | 5.6 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Vivesto bjuder in till livesänd R&D Update med fokus på Paccal Vet den 26 mars
Första patienten doserad i Vivestos kliniska studie med Paccal Vet
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools